Telomir Pharmaceuticals (TELO) Liabilities and Shareholders Equity (2022 - 2026)
Telomir Pharmaceuticals (TELO) posted Liabilities and Shareholders Equity of $5.37 million for Q2 2026, up 546.8% from $829,611 a year earlier.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Telomir Pharmaceuticals' Liabilities and Shareholders Equity came in at $7.34 million, up 454.5% from FY2024.
- Annual Liabilities and Shareholders Equity shows a three-year compound annual growth rate of 432.1% (FY2022 to FY2025).
- In prior years, Telomir Pharmaceuticals' Liabilities and Shareholders Equity was $1.32 million in FY2024 (-72.3%), $4.77 million in FY2023 and $48,730 in FY2022.
- Quarterly Liabilities and Shareholders Equity has run from a low of $48,730 in Q4 2022 to a high of $7.4 million in Q3 2025 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last six quarters, with growth averaging 232.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Telomir Pharmaceuticals | 82.53 Mn | 82.53 Mn | - | 5.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.37 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 829,611.00 |
| Mar 31, 2025 | 491,188.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 48,730.00 |
API Access
Telomir Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();